OMC
INZY
Overbrook Management Corp’s Inozyme Pharma INZY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-219,326
| Closed | -$200K | – | 49 |
|
|
2025
Q1 | $200K | Hold |
219,326
| – | – | 0.05% | 46 |
|
|
2024
Q4 | $608K | Hold |
219,326
| – | – | 0.13% | 38 |
|
|
2024
Q3 | $1.15M | Hold |
219,326
| – | – | 0.26% | 35 |
|
|
2024
Q2 | $978K | Hold |
219,326
| – | – | 0.25% | 36 |
|
|
2024
Q1 | $1.68M | Hold |
219,326
| – | – | 0.45% | 32 |
|
|
2023
Q4 | $934K | Hold |
219,326
| – | – | 0.19% | 39 |
|
|
2023
Q3 | $921K | Hold |
219,326
| – | – | 0.21% | 36 |
|
|
2023
Q2 | $1.22M | Hold |
219,326
| – | – | 0.29% | 32 |
|
|
2023
Q1 | $1.26M | Hold |
219,326
| – | – | 0.33% | 32 |
|
|
2022
Q4 | $230K | Buy |
219,326
+150,000
| +216% | +$158K | 0.07% | 72 |
|
|
2022
Q3 | $186K | Hold |
69,326
| – | – | 0.05% | 76 |
|
|
2022
Q2 | $331K | Buy |
69,326
+52,600
| +314% | +$251K | 0.1% | 62 |
|
|
2022
Q1 | $68K | Hold |
16,726
| – | – | 0.02% | 93 |
|
|
2021
Q4 | $114K | Hold |
16,726
| – | – | 0.02% | 98 |
|
|
2021
Q3 | $194K | Hold |
16,726
| – | – | 0.04% | 85 |
|
|
2021
Q2 | $285K | Hold |
16,726
| – | – | 0.06% | 78 |
|
|
2021
Q1 | $331K | Hold |
16,726
| – | – | 0.07% | 68 |
|
|
2020
Q4 | $345K | Hold |
16,726
| – | – | 0.08% | 68 |
|
|
2020
Q3 | $440K | Buy |
+16,726
| New | +$440K | 0.1% | 82 |
|